Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

IOncology

Home » IOncology
CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines

CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines

Posted by By Peter W. PENG 2025.09.29
Editor’s Note: Unlike Western countries where cutaneous melanoma predominates, acral and mucosal melanomas are more common in China. With the rapid development of immunotherapy and targeted therapy, perioperative treatment strategies…
Read More
Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration

Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration

Posted by By Mourabit Halima 2025.09.29
Editor’s Note: Set against the scenic backdrop of Qingdao’s coastline, the 11th Qingdao Breast Disease Conference, alongside the 9th “Langya Forum,” was successfully held from September 10 to 14, 2025.…
Read More
“Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer

“Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer

Posted by By Peter W. PENG 2025.09.29
Editor’s Note: In breast cancer treatment, the use of neoadjuvant therapy has become increasingly widespread, and its concepts continue to evolve—from traditional treatment models to today’s focus on individualized care…
Read More
CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology

CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology

Posted by By Peng Longmei 2025.09.29
Editor’s Note: The Chinese Society of Clinical Oncology (CSCO) has witnessed and propelled the rapid growth of oncology in China. Countless Chinese experts have matured on this platform—evolving from newcomers…
Read More
Professor Fei Ma: Ushering in a New Era of ‘Chemotherapy + Immunotherapy + Targeted Therapy’ for Advanced Triple-Negative Breast Cancer

Professor Fei Ma: Ushering in a New Era of ‘Chemotherapy + Immunotherapy + Targeted Therapy’ for Advanced Triple-Negative Breast Cancer

Posted by By Mourabit Halima 2025.09.29
Editor’s Note: The 16th Yan Zhao Breast Cancer Forum recently concluded successfully in Shijiazhuang. This forum focused on cutting-edge, multidisciplinary advances in breast cancer and promoted the standardization of breast…
Read More

Breaking New Ground in Systemic Therapy for Kidney Cancer

Posted by By Mourabit Halima 2025.09.28
Read More

Comprehensive Kidney Cancer Patient Management: A Holistic Approach

Posted by By Peng Longmei 2025.09.28
Read More

Transforming mHSPC Management: A New Era of Combination Strategies

Posted by By Peter W. PENG 2025.09.28
Read More

Breaking New Ground in mCRPC Treatment – Entering the Era of Precision Oncology

Posted by By Mourabit Halima 2025.09.28
Read More

Innovative Use of TAPD Technology in Robotic Partial Nephrectomy for Renal Hilum Tumors

Posted by By Peng Geng 2025.09.27
Read More

Posts pagination

1 2 3 … 20 Next page
Recent Posts
  • ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy
  • CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines
  • Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration
  • “Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer
  • CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top